5WHO.Reduction of maternal mortality[R].Geneva:WHO/UNFPA/UNICEF/World Bank.1999.13. 被引量：1
6Stones RW,Paterson CM,Saunders NJ,et al.Risk factors for major obstetric haemorrhage[J].Eur J Obstet Gynecol Reprod Biol,1993,48(1):15-18. 被引量：1
7Combs CA,Mruphy EL,Laros RK Jr,et al.Factors associated with postpartum hemorrhage with vaginal birth[J].Obstet Gynecol,1991,77(1):69-76. 被引量：1
8Dansereau J,Joshi AK,Helewa ME,et al.Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section[J].Am J Obstet Gynecol,1999,180(3):670-676. 被引量：1
9Hunter DJ,Schulz P,Wassenaar W,et al.Effect of carbetocin,a long-acting oxytocin analog on the postpartum uterus[J].Clin Pharmacol Ther,1992,52(1):60-67. 被引量：1
10van Dongen PW,Verbruggen MM,de Groot AN,et al.Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth[J].Eur J Obstet Gynecol Reprod Biol,1998,77(2):181-187. 被引量：1
